BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Bromodeoxyuridine

A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors.

300+ PubMed studies analyzed · Evidence Score: 42.6

Research Domains

Bromodeoxyuridine has been studied across 17 research domains including 🔬 Oncology, 🫁 Liver & Detox, ✨ Skin & Hair, 🦴 Bone & Joint, 🛡️ Immunity. The primary research focus is 🔬 Oncology with 24% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Bromodeoxyuridine, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Thiabendazole
8 shared targets
Thioinosine
7 shared targets
Mycophenolic
9 shared targets
Isopentenyladenosine
7 shared targets
Fluocinonide
6 shared targets
Melengestrol
7 shared targets
Fluvastatin
4 shared targets
Nitrofurazone
8 shared targets
Itraconazole
6 shared targets
Proscillaridin
6 shared targets
Loading evidence profile...

This evidence profile for Bromodeoxyuridine is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.